Platelet-Rich Fibrinogen for Toothlessness
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how well platelet-rich fibrin (PRF) aids healing after the extraction of a back tooth. Researchers are particularly interested in the treatment's effects on both younger individuals (ages 14-18) and older adults (ages 50-80). Half of the participants will receive PRF treatment, while the other half will not, allowing for a comparison. This study may suit those needing a back tooth removed and who are patients at the University of Nebraska Medical Center's College of Dentistry. As an unphased trial, it offers participants the opportunity to contribute to groundbreaking research that could enhance dental healing processes.
Will I have to stop taking my current medications?
If you are taking medications like NSAIDs, methotrexate, or bisphosphonates, you may need to stop, as these drugs can delay wound healing. The trial does not specify a washout period, but it's important to discuss your current medications with the study team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
A previous study found that using platelet-rich fibrin (PRF) in surgical areas after tooth extractions reduced pain and bleeding. Another study showed that PRF can prevent infections and reported no unusual side effects. Research has also found that PRF can stop bleeding after surgery and prevent other complications. Overall, PRF appears well-tolerated and safe for use in dental procedures.12345
Why are researchers excited about this trial?
Platelet-rich fibrin (PRF) is unique because it uses a natural concentration of growth factors derived from the patient's own blood to aid in healing after tooth extraction. Unlike traditional methods that might rely on synthetic materials or medications to promote gum and bone recovery, PRF is a minimally invasive approach that can enhance tissue regeneration. Researchers are excited about this technique because it not only reduces the risk of rejection and infection but also accelerates the healing process by delivering a high concentration of healing proteins directly to the site of extraction. This personalized approach could transform post-extraction care, especially for younger and older patients who may have varying healing capabilities.
What evidence suggests that platelet-rich fibrin could be effective for oral wound healing?
Studies have shown that platelet-rich fibrin (PRF) greatly improves soft tissue healing after tooth extractions. Research indicates that PRF reduces swelling and pain, leading to less need for painkillers. It also helps prevent dry sockets, a common issue after tooth removal, especially in the first week. Additionally, about two-thirds of studies found that PRF reduces pain in the first few days after surgery. In this trial, some participants will receive PRF treatment after tooth extraction, while others will not, allowing for a comparison of recovery outcomes. Overall, PRF aids recovery after dental procedures by speeding up healing and reducing discomfort.678910
Who Is on the Research Team?
Amy C Killeen, DDS, MS
Principal Investigator
University of Nebraska
Are You a Good Fit for This Trial?
This trial is for individuals who need a posterior tooth extraction. It includes two age groups: young people aged 14-18 and older adults aged 50-80. Participants must be healthy enough to undergo the procedure, but specific inclusion and exclusion criteria are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo posterior tooth extraction and receive platelet-rich fibrinogen (PRF) treatment or no treatment
Post-operative Follow-up
Participants return for suture removal and evaluation of healing site, with additional soft tissue sampling
Final Follow-up
Participants return for a final post-operative radiograph and assessment of bone density for implant planning
What Are the Treatments Tested in This Trial?
Interventions
- Platelet-rich fibrin (PRF)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Nebraska
Lead Sponsor